Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers
Abstract Treatment of cancers in the lung remains a critical challenge in the clinic for which gene therapy could offer valuable options. We describe an effective approach through systemic injection of engineered polymer/DNA nanoparticles that mediate tumor-specific expression of a therapeutic gene,...
Main Authors: | Hye-Hyun Ahn, Christine Carrington, Yizong Hu, Heng-wen Liu, Christy Ng, Hwanhee Nam, Andrew Park, Catherine Stace, Will West, Hai-Quan Mao, Martin G. Pomper, Christopher G. Ullman, Il Minn |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-89124-4 |
Similar Items
-
Optimization of a syngeneic murine model of bone metastasis
by: Henry P. Farhoodi, et al.
Published: (2020-08-01) -
Decidual-Placental Immune Landscape During Syngeneic Murine Pregnancy
by: Yan Li, et al.
Published: (2018-09-01) -
Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies
by: Jasneet Kaur Khalsa, et al.
Published: (2021-02-01) -
Histopathological characterization of a syngeneic orthotopic murine bladder cancer model
by: Daher C. Chade, et al.
Published: (2008-03-01) -
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
by: Jasneet Kaur Khalsa, et al.
Published: (2020-08-01)